DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

AstraZeneca plc (ADR) (NYSE: AZN)

68.18 0.39 (0.58%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AZN $68.18 0.58%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $68.05
Previous Close $67.79
Daily Range $68.05 - $68.64
52-Week Range $61.80 - $82.68
Market Cap $86.1B
P/E Ratio 33.23
Dividend (Yield) $3.80 (4.1%)
Ex-Dividend Date
Dividend Pay Date
02/18/15
03/23/15
Volume 1,079,689
Average Daily Volume 1,927,110
Current FY EPS $4.23

Sector

Healthcare

Industry

Drug Makers

AstraZeneca plc (ADR) (AZN) Description

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation. Website: http://www.astrazeneca.com/

News & Commentary

Pfizer Inc. Has a Growth Problem -- Here Are 3 Ways to Change That

This year will likely mark Pfizer's fifth consecutive year of revenue declines. But a quick solution to its growth concerns could lie within one (or more) of these three proposed fixes.

Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog

European Markets Close Lower As Conflicting Reports Circulate Regarding Third Bailout for Greece

10 Dandy Dividend Healthcare Dogs Hail 14% February Upsides

Billionaire George Soros Just Dumped These 3 Dividend Stocks

Controversial hedge fund tycoon George Soros just sold three top dividend stocks. Should you follow his lead?

5 Stocks With Jaw-Dropping Growth Potential

These five small-cap growth stocks could soar in 2015. Here's why.

A Quick Review Of The Asthma Market

Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog

Nektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog

Nektar Therapeutics Incurs Narrower-than-Expected Q4 Loss - Analyst Blog

Nektar CEO Howard Robin Walks Along His Own Path

See More AZN News...

AZN's Top Competitors

AZN $68.18 (0.58%)
Current stock: AZN
JNJ $102.52 (0.86%)
Current stock: JNJ
NVS $98.95 (-0.09%)
Current stock: NVS
RHHBY $32.80 (-1.07%)
Current stock: RHHBY